Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers
Completed
- Conditions
- Platelet-Derived Growth FactorDiabetic FootNeoplasms
- Interventions
- Drug: Sterile becaplermin gel vs. sterile placebo gel treatment 1
- First Posted Date
- 2008-08-25
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 563
- Registration Number
- NCT00740922
An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia
- First Posted Date
- 2008-08-05
- Last Posted Date
- 2014-03-26
- Target Recruit Count
- 498
- Registration Number
- NCT00728195
Bioavailability Study of Folic Acid in Healthy Women
Phase 1
Completed
- Conditions
- HealthyPharmacokinetics
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 12
- Registration Number
- NCT00709267
Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Phase 1
Completed
- Conditions
- Female ContraceptionContraceptionTherapeutic EquivalencyPharmacokinetics
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 53
- Registration Number
- NCT00709189
A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.
Phase 1
Completed
- Conditions
- Drug InteractionsHealthyPharmacokinetics
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 47
- Registration Number
- NCT00709982
Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Phase 1
Completed
- Conditions
- PharmacokineticsTherapeutic EquivalencyContraceptives, Oral
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 54
- Registration Number
- NCT00709644
A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.
Phase 1
Completed
- Conditions
- Drug InteractionsContraceptionPharmacokinetics
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 47
- Registration Number
- NCT00709332
A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With Bortezomib
Phase 2
Withdrawn
- Conditions
- Multiple Myeloma
- Interventions
- Drug: bortezomib; pegylated liposomal doxorubicin
A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults
Phase 1
Completed
- Conditions
- Epilepsy
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 40
- Registration Number
- NCT00701493
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Phase 2
Completed
- Conditions
- Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms
- Interventions
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2013-09-06
- Target Recruit Count
- 54
- Registration Number
- NCT00698451
© Copyright 2025. All Rights Reserved by MedPath